Bian, Shan http://orcid.org/0000-0003-4507-3003
Repic, Marko
Guo, Zhenming http://orcid.org/0000-0002-6469-414X
Kavirayani, Anoop
Burkard, Thomas http://orcid.org/0000-0002-0884-2929
Bagley, Joshua A. http://orcid.org/0000-0002-6825-4264
Krauditsch, Christian http://orcid.org/0000-0003-4933-6675
Knoblich, Jürgen A. http://orcid.org/0000-0002-6751-3404
Article History
Received: 23 February 2018
Accepted: 22 May 2018
First Online: 23 July 2018
Change Date: 22 August 2018
Change Type: Correction
Change Details: In the originally published paper, the “before” image for the afatinib condition in Fig. 6c was incorrect. Instead of an image displaying a GBM-3 neoplastic organoid before afatinib treatment, this panel showed an image from the GBM-2 control (DMSO) group before treatment. This error has now been corrected in the HTML and PDF versions of the article; the “before, afatinib” panel in Fig. 6c now shows a representative image from the indicated experiment. The color of all error bars in Fig. 6 has also been changed to black, for consistency. All statistical analysis and all conclusions presented in the article are unaffected by this error. Nevertheless, we apologize for the mistake.
Competing interests
: S.B. and J.A.K. have filed a patent application (EP 17190447.7) for use of this method in future disease modeling and preclinical investigation.